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Abstract
Background: This paper describes the development of a Cancer Awareness Measure for colorectal (CRC) cancer
(Bowel/Colorectal CAM
a) (study 1) and presents key results from a population-representative survey using the
measure (study 2).
Methods
Study 1: Items were taken from the literature and reviewed by expert groups. A series of three validation studies
assessed reliability and validity of the measure. To establish test-retest reliability, 49 people over 50 years of age
completed the Bowel/Colorectal CAM on two occasions (range 9-14 days, mean 13.5 days). Construct validity was
assessed by comparing responses from bowel cancer experts (n = 16) and the lay public (n = 35). Lastly, a brief
intervention study tested sensitivity to change with participants (n = 70) randomly allocated to be given a control
leaflet or an intervention leaflet and their responses were compared.
Study 2: 1520 respondents completed the Bowel/Colorectal CAM in a population survey carried out by TNS-British
Market Research Bureau International (TNS-BMRB) in March 2010.
Results
Study 1: Internal reliability (Cronbach’s alpha = 0.84) was high. Test-retest reliability was over r = 0.7 for warning
signs, risk factors and age people are first invited for screening, but lower (between 0.6 and 0.7) for other items
(lifetime risk, awareness of bowel cancer screening, age at risk). Bowel cancer experts achieved higher scores than
equally educated controls (54.7 [4.3] vs. 42.9 [5.7]; P < 0.001) demonstrating the measure has construct validity and
intervention participants showed higher knowledge than controls (51.4 [5.9] vs. 42.9 [5.7]; P < 0.001) suggesting the
measure is sensitive to change.
Study 2: Respondents recalled on average, one CRC sign and one risk factor. There was particularly low prompted
awareness of the signs ‘lump in the abdomen’ (64%) and ‘tiredness’ (50%) and several lifestyle risk factors for CRC,
e.g. exercise (37%).
Respondents from more affluent groups had consistently higher knowledge of signs and risk factors compared to
those from more deprived groups.
Conclusions: The Bowel/Colorectal CAM meets accepted psychometric criteria for reliability and construct validity
and should therefore provide a useful tool for assessment of CRC awareness. The population survey revealed low
awareness of several CRC signs and risk factors and emphasises the importance of continuing public education,
particularly about the link between lifestyle behaviours and CRC.
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Colorectal cancer (CRC) is the third most common can-
cer in the UK with over 38,000 people diagnosed each
year [1]. In 2008, 16,259 people died from the disease,
making it the second largest cause of cancer death [1].
Men have a lifetime risk of 1 in 16 compared with 1 in 20
for women and incidence rates are substantially higher in
socioeconomically deprived groups [2].
The average five-year survival for CRC in England is
51%, but survival rates vary by disease stage at diagnosis,
with over 93% of patients surviving a diagnosis of localised
disease (Dukes stage A) compared with just 7% of those
with distant metastases [3]. Currently, only around 13% of
cases are diagnosed at an early stage. Furthermore, survival
is significantly poorer in England than the European aver-
age (1 year survival: 72% vs 76%) [4]. Achieving earlier
diagnosis should play a role in reducing this difference [4].
Early diagnosis of CRC can be improved by ensuring
high participation in available screening programmes such
as the National Bowel Cancer Screening Programme
(NBCSP) in England, Wales and Scotland, which offers
Faecal Occult Blood Testing (FOBt) every two years to
people aged 60-74 (varying by country), with abnormal
results followed up with colonoscopy. FOBT screening
was recently estimated to achieve a 15% reduction in
mortality [5], but participation in CRC screening in the
UK, as well as worldwide, is relatively low [6].
Although screening is an important route for early diag-
nosis, it does not cover all cases or age groups, in addition,
many cases of CRC will present with symptoms in primary
care or elsewhere. The Department of Health in England
recently issued a set of ‘key messages’ for bowel cancer
which include signs and symptoms as well as risk factors
associated with the disease http://tinyurl.com/6kfs6pl.
Detectable symptoms include a persistent change in nor-
mal bowel habit, bleeding from the back passage, a lump
in the abdomen and unexplained extreme tiredness. Modi-
fiable risk factors include red and processed meat con-
sumption, body fatness and alcohol consumption [7].
Studies of public awareness of symptoms and risk factors
reveal that knowledge is poor [8-10]. For example, in a
survey of adults in the UK, 24% could not correctly name
any warning signs for CRC and over half (58%) were
unable to correctly recall any risk factors [8]. Raising
awareness of these, along with awareness of the NBCSP,
could help reduce cases, ensure earlier detection and
improve survival.
The Cancer Reform Strategy (CRS), published by the
Department of Health in 2007, emphasised the impor-
tance of raising awareness of cancer early warning signs
in the general population [11]. The National Awareness
and Early Diagnosis Initiative (NAEDI), which is a part-
nership between Cancer Research UK (CR-UK) and the
Department of Health, was set up as part of the CRS to
support and co-ordinate activities that promote earlier
diagnosis of cancer and ensure delivery of the CRS. An
early output of NAEDI was the Cancer Research UK
Cancer Awareness Measure (CAM), which is the first
validated tool to assess awareness of generic cancer
signs and risk factors, [12]. In the UK, the CAM is
being used nationally and locally to benchmark (e.g.
[13,14]) and track awareness over time, as well as to
monitor the impact of initiatives intended to improve
awareness of cancer.
Several ad-hoc scales have been devised to measure CRC
cancer awareness [15,16], but they use different question
formats (e.g. true/false questions vs. unprompted ques-
tions) making it difficult to compare across studies. A
measure of CRC awareness that follows the format of the
generic CAM will make it possible to establish current
levels of awareness and evaluate awareness-raising initia-
tives using a standardised, validated instrument.
This paper describes the development of a Cancer
Awareness Measure for colorectal cancer (Bowel/Color-
e c t a lC A M )( S t u d y1 )a n dp r esents key results from a
population-representative survey using the measure
(Study 2).
Study 1
Methods
Item generation
Items were generated using the Department of Health’s
‘bowel cancer - key messages’ [17] and the National
Institute for Health and Clinical Excellence (NICE)
‘Referral guidelines for suspected cancer’ [18]. Addi-
tional warning signs and risk factors were identified
from a review of the published and ‘grey’ literature and
current public health material (e.g. CR-UK leaflets). The
format used in the generic CAM (see [19] for further
details) was used for most items.
Items were reviewed by experts (N = 16) in CRC
(experts included a gastrointestinal and colorectal con-
sultant oncologist, a colorectal surgeon, a medical oncol-
ogist, a surgeon consultant clinical oncologist, a lead
consultant for general surgery, and a consultant general
surgeon) who considered interpretability, clarity and
accuracy. Draft versions of the measure were also used
in 17 cognitive interviews with members of the public
(aged 22-74 years). This ‘think-aloud’ method [20]
explores respondents’ comprehension of the questions,
i.e. whether specific words and phrases used in the
question are understood as intended by researchers and
adjustments are made accordingly. For example, the
warning sign ‘straining feeling’ was changed to ‘a feeling
that your bowel does not completely empty after using
the lavatory’.
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of 27 questions, including 10 on awareness of warning
signs (1 unprompted and 9 prompted), 11 on risk factors
(1 unprompted and 10 prompted), one on delay in help-
seeking, one on age at risk, one on lifetime risk of CRC,
two on awareness of UK CRC screening programmes and
one question on confidence in detecting a CRC symptom.
Awareness of warning signs and risk factors were assessed
with two items each. The first item was unprompted and
asked respondents to generate responses from memory.
The second item (prompted) presented a list of symptoms
or risk factors and asked respondents to indicate whether
they could be symptoms of CRC with response options
‘Yes’/’No’/’Don’tk n o w ’ for warning signs and a 5-point
likert agreement scale for risk factors (‘Strongly agree’ -
‘Strongly disagree’). All the Cancer Awareness Measures,
including the Bowel/Colorectal CAM are available to
download from the Cancer Research UK website [21].
Item scoring
For unprompted items assessing knowledge of warning
signs and risk factors, a score of 1 was given for each sign
or risk factor mentioned that also appeared in the
prompted item lists. Scores were added together to give
total scores for unprompted awareness of signs (maximum
score of 9) and unprompted awareness of risk factors
(maximum score of 10). For the prompted warning sign
items, ‘No’ and ‘Don’tK n o w ’ responses were combined
and scored ‘0’ and ‘Yes’ responses were scored ‘1’. For the
prompted risk factor items ‘Strongly agree’ or ‘Agree’
responses were scored ‘1’ and ‘Not sure’, ‘Disagree’ and
‘Strongly disagree’ responses were scored ‘0’. Total scores
for prompted awareness of warning signs (maximum score
of 9) and risk factors (maximum score of 10) were calcu-
lated by adding the recoded responses together.
The ‘delay in help-seeking’ item was scored from 1-10
(‘1-3 days’ - ‘Never’) (see ‘Additional File 1 - help-seeking
item’). For the ‘age at risk’ item ‘a 60 year old’ response
was scored ‘1’ and all other responses were given a score
of ‘0’. The question on lifetime risk of CRC was recorded
verbatim and recoded to reflect accuracy of response with
‘5’ or ‘6’ (out of 100) given a score of ‘1’ (accurate) and all
other estimates scored ‘0’ (inaccurate) (see Additional
File 2 - lifetime risk item). For the item measuring aware-
ness of the NHS Bowel Cancer Screening Programme ‘No’
and ‘Don’t know’ responses were combined and scored ‘0’
and ‘Yes’ responses were scored ‘1’. Responses to the item
asking what age people were first invited to screening
were recorded verbatim and recoded so that ‘at 60 years’
was scored ‘1’ (accurate) and all other responses were
scored ‘0’ (inaccurate). The ‘confidence in detecting a
symptom’ item was scored from 1-4 (’Not at all confident’
- ‘Very confident’).
A ‘total knowledge score’ was calculated by adding the
total score for prompted warning signs and risk factors
to scores for items: age at risk of CRC, lifetime risk,
awareness of the NHS Bowel Cancer Screening Pro-
gramme and the age people are first invited.
Participants
Sample 1 49 people recruited from four 50-plus commu-
nity centres across three London boroughs (Westminster,
Hackney, Kensington and Chelsea) completed supervised
paper-and-pencil versions of the CAM on two occasions
approximately two weeks apart. Test-retest reliability
assesses the consistency of a measure over time and is
therefore dependent on the stability of the measured con-
struct, in this case, awareness of CRC. It was therefore
important to leave adequate time to ensure that respon-
dents did not recall their previous responses to the Bowel/
Colorectal CAM, while minimising the likelihood that
their knowledge about CRC changed during the interven-
ing period. Participants were aged between 54 and 91
(mean 69 years), 90% were from a White ethnic back-
ground, most (71%) were retired, and 20% had no formal
qualifications. They were paid £5 for completing the ques-
tionnaire on two occasions.
Sample 2 70 University College London administrative
staff volunteered to complete an online version of the
C A Mi nr e s p o n s et oa ne m a i la b o u tt h es t u d y .H a l f
received CR-UK’s educational leaflet (n = 35) (’Bowel Can-
cer: The Facts’), while the others received a control leaflet
(n = 35) (’Recycle to Save the Environment’).
Sample 3 16 experts on bowel cancer from charities
committed to raising awareness of CRC (’Beating Bowel
Cancer’ and ‘Bowel Cancer UK’) completed an online
version of the questionnaire. These experts were different
from those that helped to generate items and review the
Bowel/Colorectal CAM.
Participant data was anonymised at all times and there-
fore this research was exempt from ethical approval.
Analyses
Validation of the Bowel/Colorectal CAM included analysis
of test-retest reliability using Pearson’s correlation; internal
reliability was assessed using Cronbach’s alpha; specific
item analyses (item difficulty and item discrimination ana-
lyses) were analysed by examining simple descriptive
statistics (e.g. percentages) and construct validity and sen-
sitivity to change were analysed using Chi-Square and
t-tests.
Results
Reliability
Test-retest reliability was assessed using data from sam-
ple 1 (n = 49) who completed the measure twice over
an interval of approximately 14 days (range 9-14 days;
mean 13.5 days). Test-retest reliability was high for
prompted warning signs (r = 0.77, P < .001); prompted
risk factors (r = 0.78, P < .001)
b; and age invited for
screening (r = 0.71, P < .001), and moderate for lifetime
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awareness of the CRC screening programme (r = 0.65,
P < .001) and total knowledge score (r = 0.69, P < .001).
Samples 1 and 2 were combined to assess internal
reliability (n = 119). Two items were excluded, one on
‘delay in help-seeking’ and one on ‘confidence in detect-
ing a CRC symptom’ b e c a u s et h e yd i dn o tr e l a t et o
awareness or knowledge of CRC but instead provided
an indication of perceived behavioural response in rela-
tion to symptom detection (delay in help-seeking) and
perceived self-efficacy (confidence in detecting a CRC
symptom). When using Cronbach’s alpha, a minimum
score of 0.7 is needed for a questionnaire to be consid-
ered reliable [22] and the results were good, with a
Cronbach’s alpha of 0.84 for the whole questionnaire,
0.73 for prompted warning signs and 0.79 for the
prompted risk factors subscale.
Item discrimination and difficulty
A highly discriminating item indicates that the participants
who had high awareness scores answered that item cor-
rectly whereas those with low awareness scores answered
it incorrectly. Useful items have an item-to-total correla-
tion greater than 0.2 [23]. Combining results from Sam-
ples 1 and 2 (n = 119), all items met this criterion except
for recognition of the symptom ‘blood in stools’.A st h i s
item is part of the Department of Health’s key messages
for bowel cancer [17], it was considered important in
terms of face validity and retained.
Item difficulty was assessed using results from Samples 1
(n = 49) and from the control group from Sample 2 (n =
35) on all items where it was possible to ascertain a ‘cor-
rect’ answer. Items should be retained if they are answered
correctly by more than 20% and fewer than 80% of respon-
dents [24]. Most items met these criteria, with four excep-
tions: two warning signs received higher rates of correct
answers (>80% correct) (rectal bleeding and blood in
stools), and one risk factor (diabetes) and the item on life-
time risk received a lower percentage of correct answers
(<20% correct), but these items were retained for reasons
of face validity.
Construct validity
To establish construct validity, the ‘known-groups’ method
was used where responses from experts are compared with
a lay sample. Construct validity is supported when a ques-
tionnaire can discriminate between a groups of individuals
known to have different levels of knowledge [25]. Sample
2 (control group only, n = 35) and Sample 3 (CRC experts,
n=16) were used in these analyses. There were no signifi-
cant differences in age, gender, ethnicity, educational qua-
lifications or employment status between the groups,
although participants from the ‘lay’ group were more likely
to be married. CRC experts scored consistently higher
than the ‘lay’ sample on all sections of the CAM (see
Table 1).
Sensitivity to change
A brief educational intervention was carried out to test
whether the CAM was sensitive to increases in knowl-
edge. If the measure is sensitive to change, those given
CRC educational materials should score higher than
those given control materials. Participants from Sample
2( n = 70) were assigned to receive either a CRC infor-
mation leaflet (’Bowel cancer: The Facts’) or a leaflet
about recycling (’Recycle to Save the Environment’). The
two groups did not differ significantly in age, gender,
ethnic background, marital status, employment status or
educational qualifications. The CRC information group
scored significantly higher than the control group on all
awareness sections of the CAM (see Table 1).
Study 1 discussion
The Bowel/Colorectal CAM is a reliable and valid mea-
sure of CRC awareness, meeting standard psychometric
criteria. Reliability was high, with a total Cronbach’s
alpha of 0.84 and all subscales above the recommended
level of ≥ 0.7 [21] and it had test-retest reliability over the
recommended r = 0.7 [24] for warning signs, risk factors
and the item on age people are first invited for screening.
Slightly lower correlations (between 0.6 and 0.7) were
obtained for some items (lifetime risk, awareness of
bowel cancer screening, age at risk and the total Bowel/
Colorectal CAM score). This may indicate low awareness
of these issues which resulted in respondents guessing
their answers. These items were retained because they
were considered to measure important components of
CRC knowledge, but could be removed should a shor-
tened version of the measure be needed. The measure
was able to distinguish between different levels of CRC
knowledge with experts scoring higher than an equally
educated comparison group. This was further supported
by the results of a brief intervention in which the mea-
sure was sensitive to increases in awareness of CRC.
Validation of the measure had some limitations which
should be noted. Different modes of administration (pen-
and-paper and online) were used in the validation stu-
dies, but mode of administration was consistent within
each sub-study. Using an unsupervised online version of
the measure to assess construct validity and sensitivity to
change was not ideal, although we had ensured that par-
ticipants could not go back to previous questions. Lastly,
although reliability was assessed with an older-adult sam-
ple, reflecting the increased risk of CRC with age and the
greater need for raised awareness in this group, the other
validation studies used well-educated, predominantly
White samples and in some cases, had small sample
sizes, therefore findings may lack generalisability.
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the Bowel/Colorectal CAM meets accepted psycho-
metric criteria for reliability and construct validity. It
should provide a useful tool for assessment of CRC
awareness, evaluating the effectiveness of education
campaigns designed to improve awareness, and making
comparisons across studies.
Since the Bowel/Colorectal CAM was validated, a
review of all the CAMs was undertaken, taking account
of extensive feedback from local partners (Primary Care
Trusts and Cancer Networks) who had used the measure
(s). As a result of this review process, the item on lifetime
risk (see ‘additional file 2 - lifetime risk item’)w a s
removed from the Bowel/Colorectal CAM. As our valida-
tion studies had indicated, this item was proving too diffi-
cult for people to answer and produced data of limited
value. In addition, the 10-item response scale for the
help-seeking item (’1-3 days’ - ‘Never’)w a sr e m o v e d
from the CAMs (including the Bowel/Colorectal CAM)
to reduce the possibility that providing prompted options
encouraged ‘socially desirable’ answers (leading to posi-
tively skewed data) (see ‘additional file 1 - help-seeking
item’).
Study 2
Method
1520 respondents completed the Bowel/Colorectal CAM
as part of a population survey carried out by TNS-BMRB
in March 2010. The TNS-BMRB Omnibus survey uses
random location sampling to obtain a population-repre-
sentative sample of Great Britain. Respondents are drawn
from a small set of homogenous streets, selected with a
probability proportional to the population after stratifica-
tion by Acorn characteristics (a geo-demographic seg-
mentation tool) and region. The sampling frame is an
amalgamation of Output Areas (used in the Census)
which on average contain 300 households. They are stra-
tified by region and within region by Acorn type, County
Table 1 Bowel/Colorectal CAM construct validity and sensitivity to change
Control (n = 35) Expert (n = 16) Intervention (n = 35)
Demographics N (%)
Age
18-34 10 (31.2) 5 (31.4) 12 (41.4)
35-54 16 (50.0) 9 (56.3) 15 (51.7)
55+ 6 (18.7) 0 (0) 2 (6.9)
Female 18 (51.4) 11 (68.7) 19 (54.3)
White ethnicity 23 (65.7) 12 (75.0) 25 (71.4)
Married/civil partner 20 (57.1) 1 (6.3)*** 17 (48.6)
Employed full time 31 (88.6) 12 (75.0) 30 (85.7)
Degree or higher 23 (65.6) 11 (68.8) 24 (68.6)
Knowledge Mean (SD)
Warning signs (unprompted recall) 1.4 (1.3) 4.9 (1.5)*** 3.6 (1.3)***
Warning signs (prompted) 5.9 (2.1) 8.1 (0.9)*** 7.7 (1.2)***
Risk factors (unprompted recall) 0.97 (1.2) 3.5 (1.9)*** 4.05 (1.6)***
Risk factors (prompted) 35.9 (3.7) 43.1 (3.7)*** 40.8 (5.5)***
N (%)
Age at risk
a 16 (45.7) 14 (87.5)** 30 (85.7)***
Bowel Cancer Screening Programme
a 11 (31.4) 15 (93.8)*** 31 (88.6)***
Age people first invited for screening
a 4 (11.4) 14 (87.5)*** 23 (65.7)***
Lifetime risk
a 8 (22.9) 12 (75.0)*** 18 (51.4)*
Mean
Total knowledge
b 42.9 (5.7) 54.7 (4.3)*** 51.4 (5.9)***
Note. Not all demographics add up to 100% due to missing data.
Note. Construct validity was assessed by comparing the ‘expert’ group with ‘controls’ and sensitivity to change was assessed by comparing the ‘intervention’
group with the ‘controls’.
a Shows those responding ‘correctly’.
b Total knowledge score’ = Warning signs (prompted) + risk factors (prompted) +age at risk + bowel screening programme + age people first invited for
screening + lifetime risk.
* indicates a statistically significant difference (P < 0.05) compared with control.
** indicates a statistically significant difference (P < 0.01) compared with control.
*** indicates a statistically significant difference (P < 0.001) compared with control.
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in terms of characteristics known to have a bearing on
individuals’ probabilities of being at home and therefore
available for interview (age, working status). Respondents
completed the CAM using a computer-assisted personal
interview (CAPI) in their own homes and in the presence
of trained interviewer. Respondent’s data were anon-
ymised at all times and therefore this research was
exempt from ethical approval.
Socio-demographic characteristics
The Omnibus survey includes several socio-demographic
questions, of which the following were used in these ana-
lyses: gender; age (dichotomised into <50 and ≥50 years
c),
ethnicity (because of small numbers in each ethnic sub-
group, ethnicity was categorised as ‘White’ vs. ‘non-
White’), marital status (married/cohabiting, not married);
highest educational qualification (degree or above, below
degree, other, no formal qualifications), and Social Eco-
nomic Group (SEG) (AB = higher/intermediate manage-
rial, administrative or professional; C1 = supervisory or
clerical, junior managerial, administrative or professional,
C2 = skilled manual workers, D = semi and unskilled
manual workers, E = state pensioners or widows (no other
earner), casual or lowest grade workers).
Analyses
Data were analysed using SPSS 14.0. Data were weighted to
ensure that the demographic profile of the sample matched
that for all adults in Great Britain aged 16 or over (using
Census data). Response rates to the Omnibus survey are
not recorded by TNS-BMRB and therefore it was not
possible to analyse differences between responders and
non-responders. Chi-square tests were used to examine
differences in CRC awareness (prompted) in relation to
gender, age, ethnicity, SEG and familiarity with cancer.
Multivariate analyses using General Linear Models assessed
whether any observed differences in knowledge (prompted)
by socio-demographic factors were independent.
Results
During the interviews, respondent were also asked if they
had ever been diagnosed with cancer, those that said they
had (n = 86) were excluded from the sample. The resulting
sample demographics are shown in Table 2 and approxi-
mate key population estimates although the sample
included a larger proportion of respondents from non-
White ethnic groups (12% vs. the census figure of 7.9%)
[26].
Awareness of warning signs and symptoms (see Table 3)
Awareness of signs and symptoms was measured with
two items, unprompted and prompted (see Study 1
Methods section for more detail).
Unprompted awareness of warning signs and symp-
toms of CRC was very poor, with average recall of less
than one sign or symptom (mean: 0.7; SD. 0.9). The
most well-recalled warning sign was ‘change in bowel
habit’ mentioned by 23%, followed by ‘blood in stools’
Table 2 Demographic profile of population
representative survey using the Bowel/Colorectal CAM
Survey sample
N (%)
Gender
Male 703 (49.0)
Female 731 (51.0)
Age
16-49 858 (59.8)
50 and over 576 (40.2)
Social Economic Group (SEG)
AB 383 (26.7)
C1 423 (29.5)
C2 303 (21.1)
D 214 (14.9)
E 112 (7.8)
Marital status
Married/co-habiting 857 (59.7)
Not married 577 (40.2)
Education
Degree or higher 368 (25.6)
Below degree 743 (51.8)
Other 58 (4.1)
No formal qualifications 253 (17.6)
Missing 12 (0.8)
Ethnicity
White 1334 (87.8)
Other 186 (12.2)
Table 3 Awareness of CRC warning signs and symptoms
(unprompted and prompted)
Sign/symptom Unprompted % (n) Prompted % (n)
Change in bowel habit 23.1 (331) 78.1 (1104)
Blood in stools 15.4 (221) 88.6 (1253)
Bleeding back passage 8.7 (124) 86.4 (1220)
Unexplained weight loss 4.1 (58) 74.9 (1058)
Pain in back passage 3.3 (47) 76.4 (1080)
Tiredness 2.0 (28) 50.1 (707)
Pain in abdomen 0.3 (4) 76.7 (1084)
Bowel does not empty 0.1 (1) 47.3 (668)
Lump in abdomen 0 (0) 64.4 (909)
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other sign and a quarter (25%) said they did not know
any signs or symptoms.
Prompted awareness was higher than for unprompted
with over 78% agreeing that a change in bowel habit,
bleeding from the back passage, or blood in stools could
be signs of bowel cancer. Less well-recognised signs
included ‘bowel does not empty’ (47%), ‘tiredness’ (50%)
and lump in abdomen (64%).
Women showed higher knowledge of signs and symp-
toms than men, they were more likely to recognise a
change in bowel habit (83% vs 72%; p =< 0.001), ‘bleed-
ing from back passage; (89% vs 83%; p = 0.004), ‘blood
in stools’ (92% vs 85%; P < 0.001), ‘pain in back passage’
(80% vs 73%; p = 0.004), ‘tiredness’ (54% vs 46%; p =
0.013, and ‘unexplained weight loss’ (79% vs 70%; P <
0.001). Older respondents were also better at recognis-
ing signs or symptoms. For example, 81% of those aged
50 or older recognised that unexplained weight loss
could be a sign compared with 71% of those younger
than 50 years.
Respondents from a White ethnic background show-
ing higher recognition of several signs and symptoms
compared with those from a non-White ethnic back-
ground including: ‘change in bowel habit’ (81% vs 64%;
P < 0.001), ‘pain in abdomen’ (79% vs 66%; P < 0.001),
‘bleeding from back passage’ (89% vs 74%; P < 0.001),
‘blood in stools’ (91% vs 75%; P < 0.001), ‘pain in back
passage’ (80% vs 60%; P < 0.001), and ‘unexplained
weight loss’ (77% vs 63%; P < 0.001).
There were also socio-economic differences, with
those from a higher SEG’sm o r el i k e l yt or e c o g n i s e
‘change in bowel habit’ (86% vs 67%; P < 0.001), ‘blood
in stools’ (93% vs 86%; p = 0.001) and ‘tiredness’ (60%
vs 49%; P < 0.001) than those from a lower SEG.
Knowing someone who had been diagnosed with can-
cer was associated with higher awareness. These respon-
dents more likely to recognise several of the signs and
symptoms of bowel cancer compared with respondents
who did not know anyone with cancer (e.g. ‘blood in
your stools’ 91% vs 75%; P < 0.001).
In multivariate analyses gender (P < 0.001), ethnicity
(P < 0.001), SEG (P < 0.001) and familiarity with cancer
(P < 0.001) were significant predictors of total
(prompted) symptom score.
Awareness of risk factors (see Table 4)
Awareness of risk factors was also assessed using an
unprompted and prompted question. Unprompted
awareness of risk factors was low with average total
recall of just over one (mean: 1.4; SD. 1.4). The most
well-recalled risk factor was having a close relative with
the disease, mentioned by 20%, followed by alcohol
(19%). Fewer than 10% of respondents named any other
risk factor and 28% said they could not name any.
Prompted awareness was highest for having a close
relative with bowel cancer (65%) and bowel disease
(62%). But less than half the respondents thought that
having less than five portions of fruit and vegetables and
drinking more than one unit of alcohol could increase
the risk of bowel cancer (47% and 46% respectively).
Less well-recognised risk factors included having dia-
betes (26%), low levels of physical activity (37%) and
high red or processed meat consumption (41%).
Men were more likely to know about links between
lifestyle behaviours and CRC than women; for example
64% agreed that being overweight could be a risk factor
compared with 55% of women, and 42% thought a
lower level of physical activity was associated with
increased bowel cancer risk compared with 33% of
women. Older respondents were more likely to know
that low fibre could increase the risk of bowel cancer
(67% vs 57%; P < 0.001), but those younger than 50
were more aware of the risks associated with drinking
alcohol (49% vs 41%; p = 0.009) and older age (49% vs
40%; p = 0.004).
Although respondents from a non-White background
were less likely overall to recall risk factors for bowel
cancer, they were more likely to identify consumption of
red and processed meat (50% vs 39%; p = 0.004), low-
levels of physical activity (46% vs 35%; p = 0.001) and
having diabetes (32% vs 24%; p = 0.018) as risk factors
compared with White respondents.
The strongest differences were observed for SEG.
Respondents from a higher social group more likely to
know about several risk factors for bowel cancer com-
pared to those from a lower social group (fruit and
vegetables (63% vs 41%; P < 0.001), red and processed
meat (50% vs 29%; P < 0.001), fibre (72% vs 56%; P <
0.001), overweight (66% vs 49%; p = 0.004), and exercise
(44% vs 29%; p = 0.004).
Table 4 Awareness of CRC risk factors (unprompted and
prompted)
Risk factor Unprompted % (n) Prompted % (n)
Close relative with CRC 19.5 (280) 65.3 (909)
Drinking alcohol 18.6 (266) 46.1 (636)
Low physical activity 8.7 (124) 36.9 (508)
Overweight 2.8 (41) 59.1 (814)
Older age 2.7 (38) 45.3 (629)
Low fibre 2.1 (31) 61.0 (844)
Red and processed meat 0.8 (12) 41.1 (566)
Low fruit & vegetables 0.8 (12) 47.4 (663)
Bowel disease 0.4 (6) 61.9 (848)
Diabetes 0.1 (1) 25.8 (345)
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(P < 0.001) were significant predictors of total (prompted)
risk factor score.
Study 2 discussion
Awareness of signs and symptoms of CRC and risk fac-
tors was low overall with respondents in this population
survey recalling on average, one CRC sign and one risk
factor. There was particularly low awareness of lump in
the abdomen and tiredness, both key messages for CRC
http://tinyurl.com/6kfs6pl. Efforts to inform the public
about detectable signs and symptoms of CRC are impor-
tant, especially for symptoms that are more strongly
associated with a diagnosis of CRC, (e.g. bleeding from
the back passage) and particularly in older adults who
are at most risk [27].
Awareness of several lifestyle factors associated with
CRC (e.g. exercise, red and processed meat, alcohol and
fruit and vegetable intake) was particularly poor. This has
been found previously [8,9,28-30] and demonstrates that
there is still a long way to go in educating the public
about the association between living a healthy lifestyle
and cancer risk. Public health initiatives to increase
awareness of these risk factors are essential in ensuring
better understanding of the links between lifestyle and
cancer. Greater awareness could also lead to increased
healthy behaviours [e.g. [28]] and thus could go some
way towards reducing the overall burden of ill-health on
the population.
Prompted awareness of CRC symptoms and risk factors
was much higher than unprompted awareness, particularly
for symptoms, where nearly half (47%) respondents recog-
nised the CRC symptoms presented to them. This is in
line with findings from surveys carried out using the gen-
eric CAM which also showed a much higher level of
knowledge in response to prompted than unprompted
CAM questions [13]. Further research should compare
how unprompted and prompted knowledge are related to
attitudes and help-seeking behaviour.
Women knew more CRC symptoms than men. This
has been shown in other studies [e.g. [8,10,13]] and indi-
cates that campaigns targeting men have yet to make an
impact on the gap in knowledge between the sexes (e.g.
‘Tackle it’ by Beating Bowel Cancer). There were fewer
gender differences in awareness of CRC risk factors, and
men had higher awareness of the importance of weight
and exercise. This could be because men are aware that
lifestyle risk factors are more strongly associated with
cancer in men than in women [31], or more likely
reflects men’s tendency to believe that cancer risk is
modifiable [29].
Older respondents showed higher knowledge of symp-
toms for CRC than younger respondents which is
encouraging because they are at higher risk and have a
greater need to correctly identify symptoms. However,
ironically, younger respondents were more aware of the
link between CRC and older age than older respondents.
Younger respondents also had higher awareness of alco-
hol and bowel disease as risk factors for CRC, which
could reflect better knowledge of CRC risk factors
among younger adults more generally.
Respondents from a White ethnic group had higher
knowledge of several CRC symptoms but were less good
at recognising risk factors than non-White groups.
Respondents from a Non-White ethnic background are
at lower risk of cancer overall and some groups (e.g.
Asian) show lower incidence of some cancers including
CRC [32]. Westernisation of diets, such as increased
consumption of red meat could lead to increased CRC
rates among these groups [e.g. [33,34]]. Non-White
groups are less likely to participate in screening for CRC
[ 6 ]a n ds oi ti si m p o r t a n tt h a ti n t e r v e n t i o n st or a i s e
awareness of CRC risk factors and symptoms target all
ethnic groups.
Knowing someone with CRC was associated with
higher awareness of CRC symptoms, but not risk factors.
This is not that surprising given that increased exposure
to CRC is likely to be associated with greater awareness
of the disease and its presenting symptoms and less so
with the causal processes involved. Having a family his-
tory of CRC could be more strongly associated with
knowledge of risk factors due to increased perceptions of
risk and motivations to prevent the disease [29].
More affluent groups showed higher awareness of some
CRC symptoms and were consistently more knowledge-
able about risk factors. This pattern is evident in other stu-
dies carried out in the UK and Europe [8,9,35,36] and is
also apparent in awareness of cancer in general [e.g. [13]].
CRC incidence rates in men are 11% higher in the most
deprived groups than affluent groups [2]. Raising aware-
ness of CRC symptoms and risk factors and available
screening programmes, particularly among men, is there-
fore imperative if we are to ensure that inequalities in
CRC outcomes do not increase.
Certain limitations of this study should be noted.
Response rate was not recorded by the survey company
prohibiting a comparison of responders and non-
responders, but data were weighted to ensure that the
demographic profile of the sample matched that for all
adults in Great Britain aged 16 or over (using Census
data). It should also be acknowledged that the Bowel/
Colorectal CAM was administered using computer-
assisted personal interviews (CAPI), a method which
had not been utilised in the validation of the measure.
CAPI combines the benefits of face-to-face interviewing,
such as encouraging longer responses to open-ended
(unprompted) questions while minimising some of the
disadvantages, such as social desirability bias and
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Page 8 of 10reluctance to disclose sensitive information [37]. Never-
theless, further research is needed to understand the
impact of delivery mode on the reliability and validity of
the Bowel/Colorectal CAM.
Conclusions
The Bowel/Colorectal CAM meets accepted psychometric
criteria for reliability and construct validity and should
provide a useful tool for assessing CRC awareness, evaluat-
ing the effectiveness of education campaigns designed to
improve awareness, and comparing across studies.
Public awareness of CRC symptoms and risk factors
remains stubbornly low emphasising the importance of
continuing to educate the public, particularly about the
link between lifestyle behaviours and cancer risk. Commu-
nicating messages about cancer symptoms and risk factors
is not easy because many cancer concepts and vocabulary
are difficult to understand and people tend to get the gist
but not the detail [38]. In addition, media messages can
often be misleading [e.g. “Red wine can help prevent
breast cancer” [39]] which adds further confusion. Efforts
are needed to ensure that public health messages are con-
sistent and coordinated and created using insights from
the cancer communication literature. Awareness of symp-
toms and risk factors may be associated with more positive
attitudes towards CRC and could also lead to increased
engagement with screening [8], which may significantly
reduce CRC incidence and mortality [5,40].
Endnotes
a. The Bowel/Colorectal CAM can be downloaded
from the Cancer Research UK website: http://tiny.cc/
m7bn1
b. It is not appropriate to test unprompted items for
internal reliability (Cronbach’s alpha) or test-retest
reliability.
c. 95% of CRC cases occur in those aged 50 and over [2].
Additional material
Additional file 1: Help-seeking item.
Additional file 2: Lifetime risk question.
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